1887

Journal of General Virology header logo

Volume 86, Issue 11

Herpes simplex virus type 1 immediate-early protein ICP0 diffuses out of infected rabbit corneas Free

Abstract

Herpes stromal keratitis (HSK) results from infection of herpes simplex virus (HSV) in the cornea. Recurrent HSV infection is a leading cause of corneal scarring and visual loss. Although it is generally thought that HSK is the result of an immune response to one or more viral proteins, no viral proteins have been detected in HSK corneas. Thus, the viral proteins involved in HSK, if any, remain undetermined. In contrast, it is reported here that when HSK corneal buttons from latently infected rabbits were fixed using standard procedures, the important immediate-early HSV-1 protein ICP0 was readily detected in the fixative by Western blotting. Similarly, when HSK corneal buttons were soaked in buffer (rather than fixative), ICP0 was readily detected in the soaking buffer. Other HSV-1 proteins were not detected either in the fixative or in the soaking buffer. It is also reported here that ICP0 was consistently detected in virus-free tears from the eyes of rabbits acutely infected with HSV-1. These results suggest that ICP0 rapidly diffuses out of the cornea and may explain why ICP0 was detected in the fixative of HSK corneas and in the soaking buffer of acutely infected corneas.

  • Received:
  • Accepted:
  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81246-0
2005-11-01
2024-04-23
Loading full text...

Full text loading...

/deliver/fulltext/jgv/86/11/2979.html?itemId=/content/journal/jgv/10.1099/vir.0.81246-0&mimeType=html&fmt=ahah

References

  1. Ackermann M., Braun D. K., Pereira L., Roizman B. 1984; Characterization of herpes simplex virus 1 alpha proteins 0, 4, and 27 with monoclonal antibodies. J Virol 52:108–118
     [Google Scholar]
  2. Avery A. C., Zhao Z. S., Rodriguez A., Bikoff E. K., Soheilian M., Foster C. S., Cantor H. 1995; Resistance to herpes stromal keratitis conferred by an IgG2a-derived peptide. Nature 376:431–434 [CrossRef]
     [Google Scholar]
  3. Banerjee K., Deshpande S., Zheng M., Kumaraguru U., Schoenberger S. P., Rouse B. T. 2002; Herpetic stromal keratitis in the absence of viral antigen recognition. Cell Immunol 219:108–118 [CrossRef]
     [Google Scholar]
  4. Barsam C. A., Brick D. J., Jones C., Wechsler S. L., Perng G. C. 2005; A viral model for corneal scarring and neovascularization following ocular infection of rabbits with a herpes simplex virus type 1 (HSV-1) mutant. Cornea 24:460–466 [CrossRef]
     [Google Scholar]
  5. Bastian F. O., Rabson A. S., Yee C. L., Tralka T. S. 1972; Herpesvirus hominis: isolation from human trigeminal ganglion. Science 178:306–307 [CrossRef]
     [Google Scholar]
  6. Boutell C., Everett R. D. 2003; The herpes simplex virus type 1 (HSV-1) regulatory protein ICP0 interacts with and ubiquitinates p53. J Biol Chem 278:36596–36602 [CrossRef]
     [Google Scholar]
  7. Boutell C., Sadis S., Everett R. D. 2002; Herpes simplex virus type 1 immediate-early protein ICP0 and its isolated RING finger domain act as ubiquitin E3 ligases in vitro. J Virol 76:841–850 [CrossRef]
     [Google Scholar]
  8. Davido D. J., von Zagorski W. F., Lane W. S., Schaffer P. A. 2005; Phosphorylation site mutations affect herpes simplex virus type 1 ICP0 function. J Virol 79:1232–1243 [CrossRef]
     [Google Scholar]
  9. Deshpande S., Zheng M., Lee S., Banerjee K., Gangappa S., Kumaraguru U., Rouse B. T. 2001; Bystander activation involving T lymphocytes in herpetic stromal keratitis. J Immunol 167:2902–2910 [CrossRef]
     [Google Scholar]
  10. Deshpande S., Banerjee K., Biswas P. S., Rouse B. T. 2004; Herpetic eye disease: immunopathogenesis and therapeutic measures. Expert Rev Mol Med 6:1–14
     [Google Scholar]
  11. Everett R. D. 2000; ICP0, a regulator of herpes simplex virus during lytic and latent infection. Bioessays 22:761–770 [CrossRef]
     [Google Scholar]
  12. Everett R. D., Freemont P., Saitoh H., Dasso M., Orr A., Kathoria M., Parkinson J. 1998; The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. J Virol 72:6581–6591
     [Google Scholar]
  13. Everett R. D., Boutell C., Orr A. 2004; Phenotype of a herpes simplex virus type 1 mutant that fails to express immediate-early regulatory protein ICP0. J Virol 78:1763–1774 [CrossRef]
     [Google Scholar]
  14. Feldman L. T., Ellison A. R., Voytek C. C., Yang L., Krause P., Margolis T. P. 2002; Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc Natl Acad Sci U S A 99:978–983 [CrossRef]
     [Google Scholar]
  15. Gangappa S., Deshpande S. P., Rouse B. T. 2000; Bystander activation of CD4+ T cells accounts for herpetic ocular lesions. Invest Ophthalmol Vis Sci 41:453–459
     [Google Scholar]
  16. Garweg J. G., Russ C. E., Schellhorn M., Bohnke M., Halberstadt M. 2003; HSV-1 antigens and DNA in the corneal explant buttons of patients with non-herpetic or clinically atypical herpetic stromal keratitis. Graefe's Arch Clin Exp Ophthalmol 241:734–739 [CrossRef]
     [Google Scholar]
  17. Gu H., Roizman B. 2003; The degradation of promyelocytic leukemia and Sp100 proteins by herpes simplex virus 1 is mediated by the ubiquitin-conjugating enzyme UbcH5a. Proc Natl Acad Sci U S A 100:8963–8968 [CrossRef]
     [Google Scholar]
  18. Hagglund R., Roizman B. 2004; Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1. J Virol 78:2169–2178 [CrossRef]
     [Google Scholar]
  19. Halford W. P., Schaffer P. A. 2001; ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency. J Virol 75:3240–3249 [CrossRef]
     [Google Scholar]
  20. Hendricks R. L. 1999; Immunopathogenesis of viral ocular infections. Chem Immunol 73:120–136
     [Google Scholar]
  21. Holbach L. M., Font R. L., Wilhelmus K. R. 1991; Recurrent herpes simplex keratitis with concurrent epithelial and stromal involvement. Immunohistochemical and ultrastructural observations. Arch Ophthalmol 109:692–695 [CrossRef]
     [Google Scholar]
  22. Jackson S. A., DeLuca N. A. 2003; Relationship of herpes simplex virus genome configuration to productive and persistent infections. Proc Natl Acad Sci U S A 100:7871–7876 [CrossRef]
     [Google Scholar]
  23. Kawaguchi Y., Bruni R., Roizman B. 1997; Interaction of herpes simplex virus 1 alpha regulatory protein ICP0 with elongation factor 1delta: ICP0 affects translational machinery. J Virol 71:1019–1024
     [Google Scholar]
  24. Kawaguchi Y., Tanaka M., Yokoymama A., Matsuda G., Kato K., Kagawa H., Hirai K., Roizman B. 2001; Herpes simplex virus 1 alpha regulatory protein ICP0 functionally interacts with cellular transcription factor BMAL1. Proc Natl Acad Sci U S A 98:1877–1882
     [Google Scholar]
  25. Kaye S. B., Baker K., Bonshek R., Maseruka H., Grinfeld E., Tullo A., Easty D. L., Hart C. A. 2000; Human herpesviruses in the cornea. Br J Ophthalmol 84:563–571 [CrossRef]
     [Google Scholar]
  26. Kristensson K., Olsson Y., Sjostrand J. 1971; Axonal uptake and retrograde transport of exogenous proteins in the hypoglossal nerve. Brain Res 32:399–406 [CrossRef]
     [Google Scholar]
  27. Kristensson K., Nennesmo L., Persson L., Lycke E. 1982; Neuron to neuron transmission of herpes simplex virus. Transport of virus from skin to brainstem nuclei. J Neurol Sci 54:149–156 [CrossRef]
     [Google Scholar]
  28. Leib D. A., Coen D. M., Bogard C. L., Hicks K. A., Yager D. R., Knipe D. M., Tyler K. L., Schaffer P. A. 1989; Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J Virol 63:759–768
     [Google Scholar]
  29. Leib D. A., Harrison T. E., Laslo K. M., Machalek M. A., Moorman N. J., Virgin H. W. 1999; Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J Exp Med 189:663–672 [CrossRef]
     [Google Scholar]
  30. Liesegang T. J. 2001; Herpes simplex virus epidemiology and ocular importance. Cornea 20:1–13 [CrossRef]
     [Google Scholar]
  31. Lin R., Noyce R. S., Collins S. E., Everett R. D., Mossman K. L. 2004; The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes. J Virol 78:1675–1684 [CrossRef]
     [Google Scholar]
  32. Ling P. D., Lednicky J. A., Keitel W. A. 10 other authors 2003; The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: a 14-month longitudinal study. J Infect Dis 187:1571–1580 [CrossRef]
     [Google Scholar]
  33. Loiacono C. M., Taus N. S., Mitchell W. J. 2003; The herpes simplex virus type 1 ICP0 promoter is activated by viral reactivation stimuli in trigeminal ganglia neurons of transgenic mice. J Neurovirol 9:336–345 [CrossRef]
     [Google Scholar]
  34. Metcalf J. F., Kaufman H. E. 1976; Herpetic stromal keratitis: evidence for cell-mediated immunopathogenesis. Am J Ophthalmol 82:827–834 [CrossRef]
     [Google Scholar]
  35. Metcalf J. F., Helmsen R. 1977; Immunoelectron microscopic localization of herpes simplex virus antigens in rabbit cornea with antihuman IgG–antiferritin hybrid antibodies. Invest Ophthalmol Vis Sci 16:779–786
     [Google Scholar]
  36. Meyers-Elliott R. H., Pettit T. H., Maxwell W. A. 1980; Viral antigens in the immune ring of herpes simplex stromal keratitis. Arch Ophthalmol 98:897–904 [CrossRef]
     [Google Scholar]
  37. Miyamoto K., Morgan C., Hsu K. C., Hampar B. 1971; Differentiation by immunoferritin of herpes simplex antigens with the use of rabbit 7S and 19S antibodies from early (7-day) and late (7-week) immune sera. J Natl Cancer Inst 46:629–646
     [Google Scholar]
  38. Mossman K. L., Saffran H. A., Smiley J. R. 2000; Herpes simplex virus ICP0 mutants are hypersensitive to interferon. J Virol 74:2052–2056 [CrossRef]
     [Google Scholar]
  39. Parkinson J., Lees-Miller S. P., Everett R. D. 1999; Herpes simplex virus type 1 immediate-early protein Vmw110 induces the proteasome-dependent degradation of the catalytic subunit of DNA-dependent protein kinase. J Virol 73:650–657
     [Google Scholar]
  40. Pavan-Langston D. 2000; Herpes simplex of the ocular anterior segment. Curr Clin Top Infect Dis 20:298–324
     [Google Scholar]
  41. Pepose J. S. 1991; Herpes simplex keratitis: role of viral infection versus immune response. Surv Ophthalmol 35:345–352 [CrossRef]
     [Google Scholar]
  42. Perng G. C., Dunkel E. C., Geary P. A., Slanina S. M., Ghiasi H., Kaiwar R., Nesburn A. B., Wechsler S. L. 1994; The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency. J Virol 68:8045–8055
     [Google Scholar]
  43. Perng G. C., Jones C., Ciacci-Zanella J. & 8 other authors (2000a). Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science 287:1500–1503 [CrossRef]
     [Google Scholar]
  44. Perng G. C., Slanina S. M., Yukht A., Ghiasi H., Nesburn A. B., Wechsler S. L. 2000b; The latency-associated transcript gene enhances establishment of herpes simplex virus type 1 latency in rabbits. J Virol 74:1885–1891 [CrossRef]
     [Google Scholar]
  45. Pettit T. H., Meyers R. L. 1976; Stromal herpes simplex keratitis. Trans Pac Coast Oto-Ophthalmol Soc 57:253–261
     [Google Scholar]
  46. Piatigorsky J. 2001; Enigma of the abundant water-soluble cytoplasmic proteins of the cornea: the “refracton” hypothesis. Cornea 20:853–858 [CrossRef]
     [Google Scholar]
  47. Pramod N. P., Gopalakrishnan V., Mohan R., Chandriga S., Anandakannan K., Menon T., Thyagarajan S. P. 1998; Enhanced detection of herpes simplex virus from ocular specimens of herpetic keratitis patients. Indian J Pathol Microbiol 41:49–53
     [Google Scholar]
  48. Roizman B., Sears A. E. 1996; Herpes simplex viruses and their replication. In Fields Virology , 3rd edn. pp  2231–2295 Edited by Fields B. N., Knipe D. M., Howley P. M. Philadelphia: Lippincott–Raven;
     [Google Scholar]
  49. Sacks W. R., Schaffer P. A. 1987; Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture. J Virol 61:829–839
     [Google Scholar]
  50. Shimeld C., Efstathiou S., Hill T. 2001; Tracking the spread of a lacZ -tagged herpes simplex virus type 1 between the eye and the nervous system of the mouse: comparison of primary and recurrent infection. J Virol 75:5252–5262 [CrossRef]
     [Google Scholar]
  51. Stevens J. G. 1989; Human herpesviruses: a consideration of the latent state. Microbiol Rev 53:318–332
     [Google Scholar]
  52. Stevens J. G., Nesburn A. B., Cook M. L. 1972; Latent herpes simplex virus from trigeminal ganglia of rabbits with recurrent eye infection. Nat New Biol 235:216–217 [CrossRef]
     [Google Scholar]
  53. Stow N. D., Stow E. C. 1986; Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110. J Gen Virol 67:2571–2585 [CrossRef]
     [Google Scholar]
  54. Streilein J. W., Dana M. R., Ksander B. R. 1997; Immunity causing blindness: five different paths to herpes stromal keratitis. Immunol Today 18:443–449 [CrossRef]
     [Google Scholar]
  55. Zhao Z. S., Granucci F., Yeh L., Schaffer P. A., Cantor H. 1998; Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 279:1344–1347 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.81246-0
Loading
Herpes simplex virus type 1 immediate-early protein ICP0 diffuses out of infected rabbit corneas
J. Gen. Virol. 86, 2979 (2005); https://doi.org/10.1099/vir.0.81246-0
/content/journal/jgv/10.1099/vir.0.81246-0
/content/journal/jgv/10.1099/vir.0.81246-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error